Benchmark Starts DexCom (DXCM) at Buy
Benchmark analyst Bruce Jackson initiates coverage on DexCom (NASDAQ: DXCM) with a Buy rating.The analyst comments "We are initiating coverage ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
